Mevia AB
PrivateLast Round
Early Funding
Mar 11, 2022
Est. Valuation
$1.81M
Total Funding Raised
$1.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mevia AB operates in Healthcare & Life Sciences and is based in Gothenburg. Its latest recorded funding round was an Early Funding round in March 2022.
Mevia AB is a healthcare services company that develops intelligent medication packaging and digital solutions to improve patient medication adherence.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Patient Engagement, Health IoT, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mevia AB Comparables
Compare Mevia AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pill Connect Limited | 89% | |
| Information Mediary Corp. | 87% | |
| iZafe Group | 79% |
For institutional investors. Book with your work email.
Mevia AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 11, 2022 | ||||
| Seed | Oct 1, 2019 | ||||
| Accelerator | Jan 16, 2019 | ||||
| Seed | Dec 17, 2015 | ||||
| Seed | Sep 1, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mevia AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Almi Invest AB | Seed |
| Chalmers Ventures | Seed, Early Funding |
| Merck Accelerator | Accelerator |
| Spira Invest AB | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 800% MoM, from 401 to 3.6K.
- Apr 2, 2026
Monthly visitors grew 448% MoM, reaching 2.9K.
For institutional investors. Book with your work email.
Mevia AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mevia AB's valuation, stock price, and market status.
Is Mevia AB a public or private company?
Mevia AB is a private company.
What is the current stock price of Mevia AB?
Mevia AB is a private company, so its shares have no public market price. Caplight tracks Mevia AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mevia AB worth (valuation)?
Mevia AB's valuation is estimated at $1.8M based on funding round data.
Can I buy Mevia AB stock?
Mevia AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mevia AB's last funding round?
Mevia AB's most recent funding round was Early Funding on March 11, 2022.
Who are the main investors in Mevia AB?
Key investors in Mevia AB include Almi Invest AB, Merck Accelerator.
Will Mevia AB IPO soon?
No public IPO plans have been announced for Mevia AB.
How can I track Mevia AB secondary market activity?
Caplight tracks bids, offers, and trades in Mevia AB's shares on secondary markets.